£246k
1 period on recordActive15731818Private limited companyLondon
SYNTEX LIMITED
Significant control: Roberto Volpe (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Syntex Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Syntex Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SYNTEX LIMITED is an active private limited company (company number 15731818) incorporated on 21 May 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 May 2025, showing net assets of £246k and cash of £248k, with 0 employees on average.
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr Roberto Volpe
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 21 May 20242 yrs ago
- Next accounts due
- 28 February 2027in 125 days
- Confirmation statement due
- 4 June 2027in 221 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£248k
1 period on recordNot reported
0
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £246k | £248k | £6 | £1,756 | — | — | 0 |
Current ratio141.22Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £246,222 at 31 May 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 141.22
- Cash at bank of £50,000 or moreCash £247,972
- Incorporated two to five years agoIncorporated 21 May 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 221 days
- Next accounts duein 125 days
- Accounts period endNet assets £246k · small accounts
- Incorporated
08
Similar companies in London
09
Reminders for SYNTEX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.